tert-Butyl 4-amino-4-(4-chlorobenzyl)piperidine-1-carboxylate

Catalog No.: 
ACMAYL759
CAS No.: 
956460-41-6
Molecular Formula: 
C17H25ClN2O2
Molecular Weight: 
324.85
tert-Butyl 4-amino-4-(4-chlorobenzyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$388.00InquiryInquiry
100mg95%$562.00InquiryInquiry
250mg95%$950.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-amino-4-(4-chlorobenzyl)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-amino-4-(4-chlorobenzyl)piperidine-1-carboxylate
MDL No.MFCD20257751
Molecular FormulaC17H25ClN2O2
Molecular Weight324.85
SMILESO=C(N1CCC(CC2=CC=C(Cl)C=C2)(N)CC1)OC(C)(C)C
InChI KeyAXMAMXSLJKFCDG-UHFFFAOYSA-N
Synonymtert-Butyl 4-amino-4-(4-chlorobenzyl)piperidine-1-carboxylate;1-PIPERIDINECARBOXYLIC ACID, 4-AMINO-4-[(4-CHLOROPHENYL)METHYL]-, 1,1-DIMETHYLETHYL ESTER;Reaxys ID: 14548419
CAS No.956460-41-6

Synthetic Route by SureRoute

1. ACMAYL759 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACMAYL759 route product structure diagram
    ACMAYL759956460-41-6
Inquiry

2. ACMAYL759 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMAYL759 route product structure diagram
    ACMAYL759956460-41-6
Inquiry

3. ACMAYL759 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMAYL759 route product structure diagram
    ACMAYL759956460-41-6
Inquiry

Comments (0)